Placental metabolic reprogramming: Do changes in the mix of energy-generating substrates modulate fetal growth?

International Journal of Developmental Biology

Volumn 54, Issue 2-3, 2010, Pages 409-419

  Illsley, Nicholas P ^a   Caniggia, Isabella ^b   Zamudio, Stacy ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Glucose; HIF 1; Hypoxia; Mitochondria; Trophoblast

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE; SUCCINATE DEHYDROGENASE;

ALTITUDE; ANAEROBIC METABOLISM; ARTICLE; BLOOD FLOW VELOCITY; FETUS GROWTH; FETUS HYPOXIA; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL VOLUME; NONHUMAN; OXYGEN TENSION; OXYGENATION; PLACENTA; PLACENTAL TRANSFER; PRIORITY JOURNAL; ANOXIA; ENERGY METABOLISM; FEMALE; FETOMATERNAL TRANSFUSION; FETUS DEVELOPMENT; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY; PREGNANCY; REVIEW;

ANOXIA; BLOOD GLUCOSE; ENERGY METABOLISM; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MATERNAL-FETAL EXCHANGE; OXYGEN CONSUMPTION; PLACENTA; PREGNANCY;

EID: 77950361139     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.082798ni     Document Type: Article

References (118)

1. AARDEMA, M.W., OOSTERHOF, H., TIMMER, A., VAN ROOY, I. and AARNOUDSE, J.G. (2001). Uterine artery doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 22: 405-411.
2. ARAGONES, J., SCHNEIDER, M., VAN GEYTE, K., FRAISL, P., DRESSELAERS, T., MAZZONE, M., DIRKX, R., ZACCHIGNA, S., LEMIEUX, H., JEOUNG, N.H. et al. (2008). Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40: 170-80.
3. BAGGA, R., VASISHTA, K., MAJUMDAR, S. and GARG, S.K. (1990). Correlation between human placental lactogen levels and glucose metabolism in pregnant women with intrauterine growth retardation. Aust. N. Z. J. Obstet. Gynaecol. 30: 310-3.
4. BAUMANN, M.U., ZAMUDIO, S. and ILLSLEY, N.P. (2007). Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia- inducible factor-1. Am J Physiol Cell Physiol 293: C477-85.
5. BOWER, S., BEWLEY, S. and CAMPBELL, S. (1993). Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol. 82: 78-83.
6. BRAHIMI-HORN, C. and POUYSSEGUR, J. (2006). The role of the hypoxia- inducible factor in tumor metabolism growth and invasion. Bull Cancer 93: E73-80.
7. BROSENS, I.A., ROBERTSON, W.B. and DIXON, H.G. (1972). The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1: 177-91.
8. CAMPBELL, S., PEARCE, J.M., HACKETT, G., COHEN-OVERBEEK, T. and HERNANDEZ, C. (1986). Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol. 68: 649-53.
9. CANIGGIA, I., MOSTACHFI, H., WINTER, J., GASSMANN, M., LYE, S.J., KULISZEWSKI, M. and POST, M. (2000). Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105: 577-87.
10. CANNELL, G.R., KLUCK, R.M., HAMILTON, S.E., MORTIMER, R.H., HOOPER, W.D. and DICKINSON, R.G. (1988). Markers of physical integrity and metabolic viability of the perfused human placental lobule. Clin Exp Pharmacol Physiol 15: 837-44.
11. CARTER, A. (2000). Placental oxygen consumption. Part I: in vivo studies-a review. Placenta 21, Suppl A: S31-S37.
12. CARVER, T.D., QUICK, A.A., TENG, C.C., PIKE, A.W., FENNESSEY, P.V. and HAY, W.W., JR. (1997). Leucine metabolism in chronically hypoglycemic hypoinsulinemic growth-restricted fetal sheep. Am J Physiol 272: E107-17.
13. CASH, T.P., PAN, Y. and SIMON, M.C. (2007). Reactive oxygen species and cellular oxygen sensing. Free Radic Biol Med 43: 1219-25.
14. CHEN, J.-X. and MEYRICK, B. (2004). Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab. Invest. 84: 182-90.
15. COULET, F., NADAUD, S., AGRAPART, M. and SOUBRIER, F. (2003). Identifica- tion of hypoxia-response element in the human endothelial nitric-oxide syn- thase gene promoter. J. Biol. Chem. 278: 46230-40.
16. D'ANGEL O.G., DUPLAN, E., BOYER, N., VIGNE, P. and FRELIN, C. (2003). Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J. Biol. Chem. 278: 38183-7.
17. DAHIA, P.L. (2006). Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas. Ann N Y Acad Sci 1073: 208-20.
18. DAHIA, P.L., ROSS, K.N., WRIGHT, M.E., HAYASHIDA, C.Y., SANTAGATA, S., BARONTINI, M., KUNG, A.L., SANSO, G., POWERS, J.F., TISCHLER, A.S. et al. (2005). A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1: 72-80.
19. DEDKOVA, E.N., JI, X., LIPSIUS, S.L. and BLATTER, L.A. (2004). Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am J Physiol Cell Physiol 286: C406-15.
20. DELMIS, J., DRAZANCIC, A., IVANISEVIC, M. and SUCHANEK, E. (1992). Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. J. Perinat. Med. 20: 47-56.
21. ECONOMIDES, D.L. and NICOLAIDES, K.H. (1989). Blood glucose and oxygen tension levels in small-for-gestational-age fetuses.[see comment]. Am. J. Obstet. Gynaecol. 160: 385-9.
22. ERUSALIMSKY, J.D. and MONCADA, S. (2007). Nitric Oxide and Mitochondrial Signaling. From Physiology to Pathophysiology. Arterioscler Thromb Vasc Biol.
23. ESTERMAN, A., GRECO, M.A., MITANI, Y., FINLAY, T.H., ISMAIL-BEIGI, F. and DANCIS, J. (1997). The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta 18: 129-36.
24. FERRAZZI, E., RIGANO, S., BOZZO, M., BELLOTTI, M., GIOVANNINI, N., GALAN, H. and BATTAGLIA, F.C. (2000). Umbilical vein blood flow in growth-restricted fetuses. Ultrasound Obstet Gynecol 16: 432-8.
25. FIRTH, J.D., EBERT, B.L. and RATCLIFFE, P.J. (1995). Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270: 21021-7.
26. FUKASAWA, M., TSUCHIYA, T., TAKAYAMA, E., SHINOMIYA, N., UYEDA, K., SAKAKIBARA, R. and SEKI, S. (2004). Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase gene. J Biochem (Tokyo) 136: 273-7.
27. GAO, W., GAO, Y., ZHANG, G., SONG, L., SUN, B. and SHI, J. (2005). Hypoxia- induced expression of HIF-1alpha and its target genes in umbilical venous endothelial cells of Tibetans and immigrant Han. Comp. Biochem. Physiol. Toxicol. Pharmacol. 141: 93-100.
28. GILES, W.B., LINGMAN, G., MARSAL, K. and TRUDINGER, B.J. (1986). Fetal volume blood flow and umbilical artery flow velocity waveform analysis: a comparison. Br J Obstet Gynaecol 93.
29. GRUPPUSO, P.A., MIGLIORI, R., SUSA, J.B. and SCHWARTZ, R. (1981). Chronic maternal hyperinsulinemia and hypoglycemia. A model for experimental intrau- terine growth retardation. Biol.Neonate 40: 113-20.
30. GUZY, R.D., SHARMA, B., BELL, E., CHANDEL, N.S. and SCHUMACKER, P.T. (2008). Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 28: 718-31.
31. HAGEN, T., TAYLOR, C.T., LAM, F. and MONCADA, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302: 1975-8.
32. HAMACHER-BRADY, A., BRADY, N.R., LOGUE, S.E., SAYEN, M.R., JINNO, M., KIRSHENBAUM, L.A., GOTTLIEB, R.A. and GUSTAFSSON, A.B. (2007). Response to myocardial ischemia/reperfusion injury involves Bnip3 and au- tophagy. Cell Death Differ 14: 146-57.
33. HAN, V.K. (1993). Pathophysiology, cellular and molecular mechanisms of foetal growth retardation. Equine Vet J Suppl 12-6.
34. HAY, W.W., JR. (2006). Recent observations on the regulation of fetal metabolism by glucose. J. Physiol. 572: 17-24.
35. HELLWIG-BURGEL, T., STIEHL, D.P., WAGNER, A.E., METZEN, E. and JELKMANN, W. (2005). Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25: 297-310.
36. HOCHACHKA, P.W. and LUTZ, P.L. (2001). Mechanism, origin, and evolution of anoxia tolerance in animals. Comp Biochem Physiol B Biochem Mol Biol 130: 435-59.
37. HOOPER, S.B. (1995). Fetal metabolic responses to hypoxia. Reprod. Fert. Dev. 7: 527-38.
38. HUBINONT, C., NICOLINI, U., FISK, N.M., TANNIRANDORN, Y. and RODECK, C.H. (1991). Endocrine pancreatic function in growth-retarded fetuses. Obstet Gynecol. 77: 541-4.
39. IETTA, F., WU, Y., WINTER, J., XU, J., WANG, J., POST, M. and CANIGGIA, I. (2006). Dynamic HIF1A regulation during human placental development. Biol Reprod 75: 112-21.
40. ILLSLEY, N.P., AARNOUDSE, J.G., PENFOLD, P., BARDSLEY, S.E., COADE, S.B., STACEY, T.E. and HYTTEN, F.E. (1984). Mechanical and metabolic viability of a placental perfusion system in vitro under oxygenated and anoxic conditions. Placenta 5: 213-25.
41. JAUNIAUX, E., WATSON, A.L. and BURTON, G. (2001). Evaluation of respiratory gases and acid-base gradients in fetal tissue and uteroplacental tissue between 7-16 weeks. Am. J. Obstet. Gynaecol. 184: 998-1003.
42. KAMEI, Y., TSUTSUMI, O., YAMAKAWA, A., OKA, Y., TAKETANI, Y. and IMAKI, J. (1999). Maternal epidermal growth factor deficiency causes fetal hypoglyce- mia and intrauterine growth retardation in mice: possible involvement of placen- tal glucose transporter GLUT3 expression. Endocrinology 140: 4236-43.
43. KAY, H.H., ZHU, S. and TSOI, S. (2007). Hypoxia and lactate production in trophoblast cells. Placenta 28: 854-60.
44. KHOUZAMI, V.A., GINSBURG, D.S., DAIKOKU, N.H. and JOHNSON, J.W. (1981). The glucose tolerance test as a means of identifying intrauterine growth retardation. Am. J. Obstet. Gynaecol. 139: 423-6.
45. KIM, J.W., TCHERNYSHYOV, I., SEMENZA, G.L. and DANG, C.V. (2006). HIF-1- mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-85.
46. KING, A., SELAK, M.A. and GOTTLIEB, E. (2006). Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25: 4675-82.
47. KINGDOM, J.C. and KAUFMANN, P. (1997). Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18: 613-21; discussion 623-6.
48. KOLOBOVA, E., TUGANOVA, A., BOULATNIKOV, I. and POPOV, K.M. (2001). Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites. Biochem J 358: 69-77.
49. KONJE, J.C., HOWARTH, E.S., KAUFMANN, P. and TAYLOR, D.J. (2003). Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction. Bjog 110: 301-5.
50. KOUMENIS, C. and WOUTERS, B.G. (2006). «Translating» tumor hypoxia: un- folded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res 4: 423-36.
51. KRECZY, A., FUSI, L. and WIGGLESWORTH, J.S. (1995). Correlation between umbilical arterial flow and placental morphology. Int. J. Gynecol. Pathol. 14: 306-9.
52. LABARRERE, C.A. and FAULK, W.P. (1994). Antigenic identification of cells in spiral artery trophoblastic invasion: validation of histologic studies by triple- antibody immunocytochemistry. Am. J. Obstet. Gynaecol. 171: 165-71.
53. LACKMAN, F., CAPEWELL, V., GAGNON, R. and RICHARDSON, B. (2001). Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am. J. Obstet. Gynaecol. 185: 674-82.
54. LAND, S.C. and RAE, C. (2005). iNOS initiates and sustains metabolic arrest in hypoxic lung adenocarcinoma cells: mechanism of cell survival in solid tumor core. American J. Physiol. - Cell Physiology 289: C918-33.
55. LANGER, O., DAMUS, K., MAIMAN, M., DIVON, M., LEVY, J. and BAUMAN, W. (1986). A link between relative hypoglycemia-hypoinsulinemia during oral glucose tolerance tests and intrauterine growth retardation. Am. J. Obstet. Gynaecol. 155: 711-6.
56. LU, D.-Y., LIOU, H.-C., TANG, C.-H. and FU, W.-M. (2006). Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochemical Phar- macology 72: 992-1000.
57. LU, H., DALGARD, C.L., MOHYELDIN, A., MCFATE, T., TAIT, A.S. and VERMA, A. (2005). Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280: 41928-39.
58. LUEDER, F.L., BUROKER, C.A., KIM, S.B., FLOZAK, A.S. and OGATA, E.S. (1992). Differential effects of short and long durations of insulin-induced maternal hypoglycemia upon fetal rat tissue growth and glucose utilization. Pediatr Res 32: 436-40.
59. LUNELL, N.O., LEWANDER, R., MAMOUN, I., NYLUND, L., SARBY, S. and THORNSTROM, S. (1984). Uteroplacental blood flow in pregnancy induced hypertension. Scand J Clin Lab Invest Suppl 169: 28-35.
60. LUNELL, N.O., SARBY, B., LEWANDER, R. and NYLUND, L. (1979). Comparison of uteroplacental blood flow in normal and in intrauterine growth-retarded pregnancy. Measurements with Indium-113m and a computer-linked gammacamera. Gynecol Obstet Invest 10: 106-18.
61. MACKENZIE, E.D., SELAK, M.A., TENNANT, D.A., PAYNE, L.J., CROSBY, S., FREDERIKSEN, C.M., WATSON, D.G. and GOTTLIEB, E. (2007). Cell-perme- ating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell. Biol. 27: 3282-9.
62. MALINSKI, T. and TAHA, Z. (1992). Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358: 676-8.
63. MARCONI, A.M., CETIN, I., DAVOLI, E., BAGGIANI, A.M., FANELLI, R., FENNESSEY, P.V., BATTAGLIA, F.C. and PARDI, G. (1993). An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies. Metabolism 42: 860-4.
64. MARCONI, A.M., PAOLINI, C., BUSCAGLIA, M., ZERBE, G., BATTAGLIA, F.C. and PARDI, G. (1996). The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol. 87: 937-42.
65. MARKERT, C.L. (1984). Lactate dehydrogenase. Biochemistry and function of lactate dehydrogenase. Cell Biochem Funct 2: 131-4.
66. MASON, S.D., RUNDQVIST, H., PAPANDREOU, I., DUH, R., MCNULTY, W.J., HOWLETT, R.A., OLFERT, I.M., SUNDBERG, C.J., DENKO, N.C., POELLINGER, L. et al. (2007). HIF-1alpha in endurance training: suppression of oxidative metabolism. American J. Physiol. - Reg. Integ. Comp. Physiol. 293: R2059-69.
67. MATRONE, C., PIGNATARO, G., MOLINARO, P., IRACE, C., SCORZIELLO, A., DI RENZO, G.F. and ANNUNZIATO, L. (2004). HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J. Neurochem. 90: 368-78.
68. MAYHEW, T.M., CHARNOCK-JONES, D.S. and KAUFMANN, P. (2004). Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 25: 127-39.
69. MEEKINS, J.W., PIJNENBORG, R., HANSSENS, M., MCFADYEN, I.R. and VAN ASSHE, A. (1994). A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Brit. J. Obstet. Gynaecol. 101: 669-74.
70. MELILLO, G., TAYLOR, L.S., BROOKS, A., MUSSO, T., COX, G.W. and VARESIO, L. (1997). Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272: 12236-43.
71. MELLOR, H.R. and HARRIS, A.L. (2007). The role of the hypoxia-inducible BH3- only proteins BNIP3 and BNIP3L in cancer. Cancer Metastat. Rev. 26: 553-66.
72. MIN, J., JIN, Y.-M., MOON, J.-S., SUNG, M.-S., JO, S.A. and JO, I. (2006). Hypoxia- induced endothelial NO synthase gene transcriptional activation is mediated through the tax-responsive element in endothelial cells. Hypertension 47: 1189- 96.
73. MOORE, L.G. (2003). Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt Med Biol 4: 141-56.
74. MOORE, L.G., NIERMEYER, S. and ZAMUDIO, S. (1998). Human adaptation to high altitude: regional and life-cycle perspectives. Am. J. Phys. Anthropol. Suppl: 25-64.
75. NEVO, O., SOLEYMANLOU, N., WU, Y., XU, J., KINGDOM, J., MANY, A., ZAMUDIO, S. and CANIGGIA, I. (2006). Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 291: R1085-93.
76. NICOLINI, U., HUBINONT, C., SANTOLAYA, J., FISK, N.M., COE, A.M. and RODECK, C.H. (1989). Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retarda- tion. Am. J. Obstet. Gynaecol. 161: 924-7.
77. PALMER, S.K., MOORE, L.G., YOUNG, D., CREGGER, B., BERMAN, J.C. and ZAMUDIO, S. (1999). Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am. J. Obstet. Gynaecol. 180: 1161-8.
78. PALMER, S.K., ZAMUDIO, S., COFFIN, C., PARKER, S., STAMM, E. and MOORE, L.G. (1992). Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol. 80: 1000-6.
79. PAN, Y., MANSFIELD, K.D., BERTOZZI, C.C., RUDENKO, V., CHAN, D.A., GIACCIA, A.J. and SIMON, M.C. (2007). Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hy- droxylase activity in vivo and in vitro. Mol. Cell. Biol. 27: 912-25.
80. PAPANDREOU, I., CAIRNS, R.A., FONTANA, L., LIM, A.L. and DENKO, N.C. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-97.
81. PARDI, G., MARCONI, A.M. and CETIN, I. (2002). Placental-fetal interrelationship in IUGR fetuses-a review. Placenta 23 Suppl A: S136-41.
82. POSTIGO, L., HEREDIA, G., ILLSLEY, N., TORRICOS, T., ECHELAR, L., TELLEZ, W., RODRIGUEZ, C., MALDONADO, I., BRIMACOMBE, M., BALANZA, E. et al. (2009). Where the O2 goes to: Preservation of human fetal oxygen deivery and consumptio at high altitude. J. Physiol. 587: 693-708.
83. POUYSSEGUR, J., DAYAN, F. and MAZURE, N.M. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-43.
84. READ, J.A., WINTER, V.J., ESZES, C.M., SESSIONS, R.B. and BRADY, R.L. (2001). Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins 43: 175-85.
85. ROSENN, B.M. and MIODOVNIK, M. (2000). Glycemic control in the diabetic pregnancy: is tighter always better? J Matern Fetal Med 9: 29-34.
86. SELAK, M.A., ARMOUR, S.M., MACKENZIE, E.D., BOULAHBEL, H., WATSON, D.G., MANSFIELD, K.D., PAN, Y., SIMON, M.C., THOMPSON, C.B. and GOTTLIEB, E. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7: 77-85.
87. SEMENZA, G.L. (1998). Hypoxia-inducible factor 1: master regulator of O2 homeo- stasis. Curr Opin Genet Dev 8: 588-94.
88. SEMENZA, G.L. (2007). Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem. J. 405: 1-9.
89. SEMENZA, G.L., AGANI, F., BOOTH, G., FORSYTHE, J., IYER, N., JIANG, B.H., LEUNG, S., ROE, R., WIENER, C. and YU, A. (1997). Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51: 553-5.
90. SEMENZA, G.L., JIANG, B.H., LEUNG, S.W., PASSANTINO, R., CONCORDET, J.P., MAIRE, P. and GIALLONGO, A. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271: 32529-37.
91. SETIA, S., SRIDHAR, M.G., BHAT, V., CHATURVEDULA, L., VINAYAGAMOORTI, R. and JOHN, M. (2006). Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology 38: 236-8.
92. SHI, Y., BAKER, J.E., ZHANG, C., TWEDDELL, J.S., SU, J. and PRITCHARD, K.A., JR. (2002). Chronic hypoxia increases endothelial nitric oxide synthase genera- tion of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circulation Res. 91: 300-6.
93. SHIBUKI, K. (1990). An electrochemical microprobe for detecting nitric oxide release in brain tissue. Neurosci Res 9: 69-76.
94. SHIME, J., MOCARSKI, E.J., HASTINGS, D., WEBB, G.D. and MCLAUGHLIN, P.R. (1987). Congenital heart disease in pregnancy: short- and long-term implications. Am. J. Obstet. Gynaecol. 156: 313-22.
95. SOKOL, R.J., KAZZI, G.M., KALHAN, S.C. and PILLAY, S.K. (1982). Identifying the pregnancy at risk for intrauterine growth retardation: possible usefulness of the intravenous glucose tolerance test. Am. J. Obstet. Gynaecol. 143: 220-3.
96. SOLEYMANLOU, N., JURISICA, I., NEVO, O., IETTA, F., ZHANG, X., ZAMUDIO, S., POST, M. and CANIGGIA, I. (2005). Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 90: 4299-308.
97. SOOTHILL, P.W., NICOLAIDES, K.H. and CAMPBELL, S. (1987). Prenatal as- phyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth re- tarded fetuses. Brit. Med. J. Clin. Res. 294: 1051-3.
98. SOOTHILL, P.W., NICOLAIDES, K.H., RODECK, C.H. and CAMPBELL, S. (1986). Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther 1: 168-75.
99. STOLZE, I.P., MOLE, D.R. and RATCLIFFE, P.J. (2006). Regulation of HIF: prolyl hydroxylases. Novartis Found Symp 272: 15-25; discussion 25-36.
100. SUGDEN, M.C. and HOLNESS, M.J. (2003). Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 284: E855-62.
101. TODROS, T., SCIARRONE, A., PICCOLI, E., GUIOT, C., KAUFMANN, P. and KINGDOM, J. (1999). Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol. 93: 499-503.
102. TRACY, K. and MACLEOD, K.F. (2007). Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy 3: 616-9.
103. VAN ASSCHE, F.A. and DE PRINS, F.A. (1983). Maternal hypoglycemia and intrauterine growth retardation. Am. J. Obstet. Gynaecol. 146: 349-50.
104. VAN VEEN, L.C., TENG, C., HAY, W.W., JR., MESCHIA, G. and BATTAGLIA, F.C. (1987). Leucine disposal and oxidation rates in the fetal lamb. Metabolism 36: 48-53.
105. WALLACE, J.M., AITKEN, R.P., MILNE, J.S. and HAY, W.W., JR. (2004). Nutrition- ally mediated placental growth restriction in the growing adolescent: conse- quences for the fetus. Biol Reprod 71: 1055-62.
106. WILLIAMS, R.L., CREASY, R.K., CUNNINGHAM, G.C., HAWES, W.E., NORRIS, F.D. and TASHIRO, M. (1982). Fetal growth and perinatal viability in California. Obstet Gynecol. 59: 624-32.
107. YAN, L., VATNER, D.E., KIM, S.J., GE, H., MASUREKAR, M., MASSOVER, W.H., YANG, G., MATSUI, Y., SADOSHIMA, J. and VATNER, S.F. (2005). Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 102: 13807-12.
108. YIP, R. (1987). Altitude and birth weight. J Pediatr 111: 869-76.
109. ZAMUDIO, S. (2003). The placenta at high altitude. High Alt Med Biol 4: 171-91.
110. ZAMUDIO, S., BAUMANN, M.U. and ILLSLEY, N.P. (2006). Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. Placenta 27: 49-55.
111. ZAMUDIO, S., KOVALENKO, O., VANDERLELIE, J., ILLSLEY, N.P., HELLER, D., BELLIAPPA, S. and PERKINS, A.V. (2007a). Chronic hypoxia in vivo reduces placental oxidative stress. Placenta 28: 846-53.
112. ZAMUDIO, S., PALMER, S., DROMA, T., STAMM, E., COFFIN, C. and MOORE, L. (1995). Effect of altitude on uterine artery blood flow during normal preg- nancy. J. Appl. Physiol. 79: 7-14.
113. ZAMUDIO, S., POSTIGO, L., ILLSLEY, N.P., RODRIGUEZ, C., HEREDIA, G., BRIMACOMBE, M., ECHALAR, L., TORRICOS, T., TELLEZ, W., MALDONADO, I. et al. (2007b). Maternal oxygen delivery is not related to altitude- and ancestry- associated differences in human fetal growth. J Physiol 582: 883-95.
114. ZAMUDIO, S., TORRICOS, T., FIK-RYMARKIEWICA, E., OYALA, M., ECHELAR, L., PULLOCKARAN, J., TUTINO, E., BELLIAPA, S., BALANZA, E. and ILLSLEY, N. (in press). Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth. PLoS ONE.
115. ZAMUDIO, S., WU, Y., IETTA, F., ROLFO, A., CROSS, A., WHEELER, T., POST, M., ILLSLEY, N.P. and CANIGGIA, I. (2007c). Human placental hypoxia- inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. Am J Pathol 170: 2171-9.
116. ZHANG, H., BOSCH-MARCE, M., SHIMODA, L.A., TAN, Y.S., BAEK, J.H., WESLEY, J.B., GONZALEZ, F.J. and SEMENZA, G.L. (2008). Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283: 10892-10903.
117. ZHANG, H., GAO, P., FUKUDA, R., KUMAR, G., KRISHNAMACHARY, B., ZELLER, K.I., DANG, C.V. and SEMENZA, G.L. (2007). HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11: 407-20.
118. ZHU, H., TANNOUS, P., JOHNSTONE, J.L., KONG, Y., SHELTON, J.M., RICHARDSON, J.A., LE, V., LEVINE, B., ROTHERMEL, B.A. and HILL, J.A. (2007). Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 117: 1782-93.